Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 4.22 -3.87% -0.17
PRTK closed down 3.87 percent on Wednesday, May 22, 2019, on 1.96 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical PRTK trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Jack-in-the-Box Bearish Bearish Swing Setup -3.87%
NR7 Range Contraction -3.87%
Lower Bollinger Band Walk Weakness -3.87%

Older signals for PRTK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Medicine Biopharmaceutical Clinical Medicine Organ Systems Infection Multiple Sclerosis SMS Antibiotics Acne Antibiotic Hepatotoxins Skin And Skin Structure Infections Community Acquired Bacterial Pneumonia Rosacea Urinary Tract Infections Anti Acne Preparations Ibd
Is PRTK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.3
52 Week Low 4.02
Average Volume 303,431
200-Day Moving Average 7.3054
50-Day Moving Average 5.574
20-Day Moving Average 5.0625
10-Day Moving Average 4.741
Average True Range 0.3483
ADX 40.62
+DI 7.3507
-DI 30.691
Chandelier Exit (Long, 3 ATRs ) 4.7101
Chandelier Exit (Short, 3 ATRs ) 5.0649
Upper Bollinger Band 5.9663
Lower Bollinger Band 4.1587
Percent B (%b) 0.03
BandWidth 35.705679
MACD Line -0.376
MACD Signal Line -0.295
MACD Histogram -0.081
Fundamentals Value
Market Cap 117.15 Million
Num Shares 27.8 Million
EPS -3.95
Price-to-Earnings (P/E) Ratio -1.07
Price-to-Sales 77.65
Price-to-Book 5.15
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.94
Resistance 3 (R3) 4.95 4.73 4.82
Resistance 2 (R2) 4.73 4.54 4.72 4.78
Resistance 1 (R1) 4.47 4.43 4.36 4.46 4.74
Pivot Point 4.25 4.25 4.19 4.24 4.25
Support 1 (S1) 3.99 4.06 3.88 3.98 3.70
Support 2 (S2) 3.77 3.95 3.76 3.66
Support 3 (S3) 3.51 3.77 3.62
Support 4 (S4) 3.50